COLUSSI, Gian Luca
 Distribuzione geografica
Continente #
NA - Nord America 3.886
AS - Asia 3.085
EU - Europa 1.645
SA - Sud America 723
AF - Africa 98
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.450
Nazione #
US - Stati Uniti d'America 3.732
SG - Singapore 1.156
IT - Italia 807
BR - Brasile 510
CN - Cina 510
VN - Vietnam 404
HK - Hong Kong 280
BD - Bangladesh 230
DE - Germania 159
FR - Francia 95
FI - Finlandia 92
JP - Giappone 84
IN - India 81
GB - Regno Unito 76
AR - Argentina 73
RU - Federazione Russa 71
ID - Indonesia 67
CA - Canada 66
PL - Polonia 61
TR - Turchia 58
NL - Olanda 55
MX - Messico 51
UA - Ucraina 45
SE - Svezia 40
AT - Austria 33
ES - Italia 32
ZA - Sudafrica 27
EC - Ecuador 25
IQ - Iraq 24
PE - Perù 24
CO - Colombia 23
SA - Arabia Saudita 23
PK - Pakistan 21
MY - Malesia 20
VE - Venezuela 20
CL - Cile 19
MA - Marocco 15
CH - Svizzera 14
PH - Filippine 14
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
IR - Iran 12
UZ - Uzbekistan 12
EG - Egitto 11
KE - Kenya 11
IE - Irlanda 10
KR - Corea 10
BO - Bolivia 9
TN - Tunisia 9
BE - Belgio 8
RS - Serbia 8
TW - Taiwan 8
JO - Giordania 7
LT - Lituania 7
UY - Uruguay 7
AZ - Azerbaigian 6
HN - Honduras 6
JM - Giamaica 6
SN - Senegal 6
TT - Trinidad e Tobago 6
AU - Australia 5
BH - Bahrain 5
IL - Israele 5
TH - Thailandia 5
CR - Costa Rica 4
DZ - Algeria 4
GT - Guatemala 4
HU - Ungheria 4
OM - Oman 4
PT - Portogallo 4
SV - El Salvador 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
ET - Etiopia 3
GE - Georgia 3
KW - Kuwait 3
KZ - Kazakistan 3
NP - Nepal 3
RO - Romania 3
CY - Cipro 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EU - Europa 2
GH - Ghana 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
MM - Myanmar 2
NO - Norvegia 2
PS - Palestinian Territory 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BT - Bhutan 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
Totale 9.426
Città #
Singapore 654
Ashburn 511
San Jose 397
Fairfield 314
Hong Kong 263
Santa Clara 254
Beijing 180
Houston 161
Dallas 146
Ho Chi Minh City 135
Woodbridge 133
Cambridge 118
Seattle 112
New York 102
Los Angeles 95
Wilmington 88
Hanoi 87
Tokyo 78
Council Bluffs 74
Helsinki 74
Milan 57
Ann Arbor 46
Ferrara 46
Lauterbourg 44
São Paulo 41
Princeton 40
Chicago 38
Gdansk 38
Redwood City 38
Chandler 37
Rome 37
Jakarta 36
Nuremberg 34
Orem 30
Buffalo 29
Munich 27
Hefei 26
Izmir 26
Frankfurt am Main 23
Jacksonville 23
Mexico City 23
Brooklyn 22
Da Nang 21
Chennai 20
Lima 20
Phoenix 20
San Diego 20
Haiphong 19
Johannesburg 19
Naples 19
Addison 18
London 18
Memphis 18
Nanjing 17
Warsaw 17
Atlanta 16
Belo Horizonte 16
Bologna 16
Moscow 16
Rio de Janeiro 16
Stockholm 16
Denver 15
Ribeirão Prêto 15
Boston 14
Washington 14
Dearborn 13
Vienna 13
Casalgrande 12
Tampa 12
Trieste 12
Turin 12
Kuala Lumpur 11
Lappeenranta 11
Manchester 11
Mountain View 11
San Francisco 11
Toronto 11
Baghdad 10
Bari 10
Jeddah 10
Montreal 10
New Delhi 10
Quito 10
Salt Lake City 10
Salvador 10
Santiago 10
Hải Dương 9
Nairobi 9
Shanghai 9
Tianjin 9
Assago 8
Boardman 8
Campinas 8
Falkenstein 8
Florence 8
Fortaleza 8
Newtown Square 8
Porto Alegre 8
Tashkent 8
Amman 7
Totale 5.482
Nome #
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 227
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 225
Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register 223
Antibiotic use and associated factors in a large sample of hospitalised older people 221
Pain and Frailty in Hospitalized Older Adults 221
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 215
Comparison between drug therapy-based comorbidity indices and the Charlson Comorbidity Index for the detection of severe multimorbidity in older subjects 201
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 198
Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people 196
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 189
Implementation of the frailty index in hospitalized older patients: results from the REPOSI register 183
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 182
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 176
Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study 175
Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients 172
Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry 172
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 170
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 170
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 162
Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients 162
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 150
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 150
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 148
Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry 143
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 142
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 141
What changed in the Italian internal medicine and geriatric wards during the lockdown 138
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 137
Initiation of Psycholeptic Medication During Hospitalization With Recommendation for Discontinuation After Discharge 137
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 133
Effects of antithrombotic agents on ophthalmological outcomes, cardiovascular risk, and mortality in hypertensive patients with retinal vein occlusion: An exploratory retrospective study 123
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 123
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 123
Plasma lipoprotein(A) levels as determinants of arterial stiffening in hypertension 119
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 119
Relation between drug therapy-based comorbidity indices, Charlson's comorbidity index, polypharmacy and mortality in three samples of older adults 119
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 114
COVID-19 Accelerated Cognitive Decline in Elderly Patients with Pre-Existing Dementia Followed up in an Outpatient Memory Care Facility 108
Diagnostic role of CD64 expression on neutrophils as biomarker for blood stream infection in liver cirrhosis: some preliminary findings 107
Elevated Intrarenal Resistive Index Predicted Faster Renal Function Decline and Long-Term Mortality in Non-Proteinuric Chronic Kidney Disease 102
Polyphenols rich diets and risk of type 2 diabetes 97
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 95
Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients 92
Effect of Combined Proteinuria and Increased Renal Resistive Index on Chronic Kidney Disease Progression: A Retrospective Longitudinal Study 90
Development and Validation of the Acute PNeumonia Early Assessment Score for Safely Discharging Low-Risk SARS-CoV-2-Infected Patients from the Emergency Department 86
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 85
‘Help yourself, so the (circadian) rhythms help you’: Chronobiological insights to promote physical and mental health 82
Dulaglutide reduces binge episodes in type 2 diabetic patients with binge eating disorder: A pilot study 81
Aortic stiffness and indexes of disease severity in subjects with previous COVID-19 penumonia:a follow-up study 77
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 75
Relationships between NAFLD biochemical scores and left ventricular geometric pattern in naive essential hypertensive patients 74
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 74
Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with covid-19 pneumonia: A prospective study 72
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 71
Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis 71
Interactions between vitamin D levels, cardiovascular risk factors, and atherothrombosis markers in patients with symptomatic peripheral artery disease 69
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 69
Role of MR-proADM and Monocyte CD169 in Predicting In-Hospital and 60-Day Mortality in COVID-19 Patients 68
Secondary hyperparathyroidism is associated with postpartum blood pressure in preeclamptic women and normal pregnancies 68
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 67
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 67
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 66
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge 66
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 64
Aldosterone and Left Ventricular Remodeling 63
Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery 62
Benzodiazepines: an old class of new antihypertensive drugs? 59
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 59
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 56
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 56
Effect of intermediate/high versus low dose heparin on the thromboembolic and hemorrhagic risk of unvaccinated COVID-19 patients in the emergency department 56
Prognostic scores and early management of septic patients in the emergency department of a secondary hospital: results of a retrospective study 52
Hypertension and type 2 diabetes: lights and shadows about causality 51
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study 50
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ 45
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 44
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 42
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 40
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 39
Has the time come to change the treatment criteria for patients with chronic kidney disease? The “hypofiltering nephron” hypothesis 38
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 38
Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study 38
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 34
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 34
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 32
HICCups and inappropriate ADH secretion syndrome as presentations of tick-borne disease 30
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 30
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 29
Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1: A systematic review and meta-analysis of randomised controlled trials 29
Novel role for SGK3 in glucose homeostasis revealed in SGK3/Akt2 double-null mice 28
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 27
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 27
Microalbuminuria and plasma aldosterone levels in nondiabetic treatment-naive patients with hypertension 27
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 26
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 25
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 24
Omega-3 polyunsaturated fatty acids decrease plasma lipoprotein(a) levels in hypertensive subjects 24
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 23
ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature 21
Diabetes, diabetic complications, and blood pressure targets 19
Totale 9.619
Categoria #
all - tutte 44.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022633 139 103 30 35 66 41 15 46 24 18 21 95
2022/2023185 39 17 6 17 17 14 28 11 19 4 8 5
2023/2024294 8 7 23 19 16 53 10 8 4 13 55 78
2024/20251.585 30 11 66 12 238 168 126 86 144 270 252 182
2025/20265.537 368 254 566 554 652 366 490 379 513 635 486 274
Totale 9.714